|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | HIV- 1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use 显示文摘 | Trkola A Kuhmann SE Strizki J M | 2002 | PNAS2002，99，： | 1 |
| 2 | SCH-C ( SCH351125 ),an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo 显示文摘 | Strizki JM Xu S Wagner NE | 2001 | Proc Natl Acad Sci USA2001，98，12： | 1 |
| 3 | Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘 | Strizki JM Tremblay C Xu S | 2005 | Antimierob Agents Chemother2005，49，12： | 1 |
| 4 | SCH-C(SCH351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1infection in vitro and in vivo 显示文摘 | Strizki JM Xu S Wagner NE | 2001 | Proc Natl Acad Sci USA2001，98，12： | 1 |
| 5 | SCH-C(SCH-351125),an orally bioavailable,small molecule antagonist of the chemokine receptor CCR5,is a potent inhibitor of HIV-1 infection in vitro and in vivo显示文摘 | Strizki JM Xu S Wagner NE | 2001 | Proc Nad Acad Sci USA2001，98，12： | 1 |
| 6 | SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CA2R5, is a potent inhibitor of HIV-1 infection in vitro and in vivo显示文摘 | Strizki JM Xu S Wagner NE | 2001 | Proc Nail Acad Sci U S A2001，98，12： | 1 |
| 7 | Infection of primary hu- man microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism显示文摘 | Strizki J M Albright A V Sheng H O'Connor M Perrin L Gonzdlez-Scarano F | 1996 | J Virol1996，70，11： | 1 |
| 8 | Combination of Vaniprevir With Peginterferon and Ribavirin Significantly Increases the Rate of SVR in Treatment-Experienced Patients With Chronic HCV Genotype 1 Infection and Cirrhosis显示文摘 | Maribel Rodriguez–Torres Albrecht Stoehr Edward J. Gane Lawrence Serfaty Eric Lawitz Amy Zhou Michael Bourque Sanhita Bhanja Julie Strizki Richard J.O. Barnard Peggy M.T. Hwang Mark J. DiNubile Niloufar Mobashery | 2014 | Clinical Gastroenterology and Hepatology2014，，： | 1 |
| 9 | Discovery and characterization of vicriviroc (SCH 417690),a CCR5 antagonist with potent activity against human immunodeficiency virus type 1显示文摘 | Strizki JM Tremblay C Xu S | 2005 | Antimicrob Agents Chemother2005，49，12： | 1 |
| 10 | Discovery and charac- terization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘 | Strizki JM Tremblay C Xu S | 2005 | Antimicrob Agents Chemother2005，49，： | 1 |
| 11 | Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘 | Strizki J M Tremblay C Xu S | 2005 | AntimicrobAg Chemother2005，49，12： | 1 |
| 12 | Discovery and characterization of vieriviroe (SCH417690), a CCR5 antagonist with potent activity against human immunodeficieney virus type 1 显示文摘 | Strizki JM Tremblay C Xu S | 2005 | Antimicrob Agents Chemother2005，49，12： | 1 |
| 13 | HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use 显示文摘 | Trkola A Kuhmann SE Strizki JM | 2002 | Proc Natl Acad Sci USA2002，99，： | 1 |
| 14 | Discovery and characterization of vicriviroc( SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘 | Strizki JM Tremblay C Xu S | 2005 | Antimicrob Agents Chemother2005，49，12： | 1 |
| 15 | HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use显示文摘 | TRKOLA A KUHMANN S STRIZKI JM | 2002 | Proc Natl Acad Sci USA2002，99，1： | 1 |
| 16 | Discovery and characteriza- tion of vieriviroc (SCH417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1显示文摘 | Strizki JM Tremblay C Xu S | 2005 | Anti- microbAgents Chemother2005，49，12： | 1 |
| 17 | SCH-C (SCH351125),an orally bioavailable,small molecule antagonist of the chemokine receptor CCR5,is a potent inhibitor of HIV-1 infection in vitro and in vivo显示文摘 | Strizki J M Xu S Wagner N E | 2001 | Proc Natl A cad Sci USA2001，98，12： | 1 |
| 18 | Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: A population and clonal analysis显示文摘 | Richard J.O. Barnard Carolyn M. McHale William Newhard Carol A. Cheney Donald J. Graham Amy L. Himmelberger Julie Strizki Peggy M.T. Hwang Amber A. Rivera Jacqueline D. Reeves David Nickle Mark J. DiNubile Daria J. Hazuda Niloufar Mobashery | 2013 | Virology2013，，2： | 1 |
| 19 | Discovery and characterization of vicriviroc (SCH 417690),a CCR5 antagonist with potent activity against human immunadeficiency virus type 1显示文摘 | Tremblay C Xu S | 2005 | Antimicrob Agents Chemother2005，49，12： | 1 |
| 20 | SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCRS, is a potent inhibitor of HIV-1 infection in vitro and in vivo显示文摘 | Strizki JM Xu S Wagner NE | 2001 | Proc Natl Acad Sci USA2001，98，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员